Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Veru Faces Compliance Concerns as Nasdaq Issues Delinquency Notice
Advancing Muscle Loss Treatment: Veru*s FDA Clearance of IND Application for Enobosarm
Muscle-Preserving Marvel: Veru*s Enobosarm Revitalizes Weight Loss Approaches
Veru Inc. Raises $33 Million Through Successful Pricing of Common Stock Offering
Veru Inc. Shatters Expectations with Phenomenal Performance During Fiscal Quarter Ending Sep 30 2023
Extremely challenging reporting period for VERU all along the most recent fiscal period
Critical quarter for Veru Inc over the July to September 30 2022 span
The company reported it had very difficult period, over the fiscal period closing Jun 30 2022
Comparatively uneventful fiscal period at VERU amid the financial second quarter of 2022